Pays: Australie
Langue: anglais
Source: Department of Health (Therapeutic Goods Administration)
Masimo Australia Pty Ltd
Class IIb
Masimo Corporation 52 Discovery, Irvine, CA, 92618 United States Of America
46201 - Pulse Co-oximeter
The non-invasive device is indicated for the continuous non-invasive monitoring of functional oxygen saturation of arterial hemoglobin (SpO2), pulse rate, carboxyhemoglobin saturation, methemoglobin saturation, total haemoglobin concentration, and/or respiratory rate. The device also has an additional mode to provide clinicians with a guided tool to help screen newborns for Critical Congenital Heart Disease (CCHD) per the established CCHD Screening protocol.
A
2018-12-20